Answers are grounded in this paper and cite their sources.
This presentation introduces BioinfoCoreLeaders-UK, an ELIXIR-UK-endorsed community bringing together leaders, managers and aspiring leaders of bioinformatics, computational biology, data science and related shared research facilities across the UK. Developed from an informal peer-support network established in 2022, the community was formally launched in Liverpool in May 2026 and consolidated at a second meeting in Warwick in September 2026. It aims to strengthen collaboration between facilities, promote sustainable service delivery models, support leadership development and career recognition, and establish a collective voice for bioinformatics core facilities within the UK research landscape. Presented at the ELIXIR-UK All Hands Meeting on 25 November 2026, these slides outline the community's origins, governance, working groups and emerging priorities. These include FAIR data and reproducibility, advocacy and responsible AI, peer support, professional development, and financial sustainability and project management. The presentation also introduces collaborative outputs under development, including an advocacy white paper on the value of bioinformatics core facilities and practical guidance for reviewing AI-generated analyses. It highlights opportunities for engagement with existing UK initiatives and invites members to contribute to the community's activities and future direction.
No takes yet. Share an insight, caveat, or question.
Caamaño‐Gutiérrez et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: